Researchers from Osaka Metropolitan University have identified a gene that, when activated by metabolic stress, damages ...

Researchers at Vertex Pharmaceuticals in Boston say a single infusion of stem cell-based treatment could be a permanent ...

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

A Canadian nurse has kicked insulin to the curb after just one dose of an experimental stem cell therapy, with experts ...

A single infusion of a new stem cell-based treatment may have helped 10 out of 12 people with severe type 1 diabetes stop using insulin, researchers report. The treatment, called zimislecel, was made ...

A woman with Type 1 diabetes said her diagnosis felt like a "death sentence" — but with a new stem cell therapy, she's now ...

A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III ...

VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...

One-year results from the company's FORWARD-101 trial of islet cell therapy zimislecel (also known as VX-880) showed that all ...

One of the first brain cells shown to make insulin is the neurogliaform cell. These live in a brain area important for ...

Australia: A recent multicentre audit conducted in Queensland, Australia, has provided compelling real-world evidence ...